These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 8380804)
21. Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection. Polak D; Naddaf R; Shapira L; Weiss EI; Houri-Haddad Y J Periodontol; 2013 Jul; 84(7):1019-25. PubMed ID: 23030239 [TBL] [Abstract][Full Text] [Related]
22. Polarization of Porphyromonas gingivalis-specific helper T-cell subsets by prior immunization with Fusobacterium nucleatum. Choi JI; Borrello MA; Smith ES; Zauderer M Oral Microbiol Immunol; 2000 Jun; 15(3):181-7. PubMed ID: 11154401 [TBL] [Abstract][Full Text] [Related]
23. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Namikoshi J; Otake S; Maeba S; Hayakawa M; Abiko Y; Yamamoto M Vaccine; 2003 Dec; 22(2):250-6. PubMed ID: 14615153 [TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis. Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095 [TBL] [Abstract][Full Text] [Related]
25. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells. Li Y; Guo H; Wang X; Lu Y; Yang C; Yang P Arch Oral Biol; 2015 Sep; 60(9):1387-93. PubMed ID: 26143497 [TBL] [Abstract][Full Text] [Related]
26. Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum. Wu T; Cen L; Kaplan C; Zhou X; Lux R; Shi W; He X J Dent Res; 2015 Oct; 94(10):1432-8. PubMed ID: 26152186 [TBL] [Abstract][Full Text] [Related]
27. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum. Liu PF; Huang IF; Shu CW; Huang CM Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430 [TBL] [Abstract][Full Text] [Related]
28. Mixed infection with Porphyromonas gingivalis and Fusobacterium nucleatum in a murine lesion model: potential synergistic effects on virulence. Feuille F; Ebersole JL; Kesavalu L; Stepfen MJ; Holt SC Infect Immun; 1996 Jun; 64(6):2094-100. PubMed ID: 8675312 [TBL] [Abstract][Full Text] [Related]
30. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis. Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489 [TBL] [Abstract][Full Text] [Related]
31. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation. Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761 [TBL] [Abstract][Full Text] [Related]
33. Relatively low invasive capacity of Porphyromonas gingivalis strains into human gingival fibroblasts in vitro. Jang JY; Baek KJ; Choi Y; Ji S Arch Oral Biol; 2017 Nov; 83():265-271. PubMed ID: 28841474 [TBL] [Abstract][Full Text] [Related]
34. Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum. Ebersole JL; Feuille F; Kesavalu L; Holt SC Microb Pathog; 1997 Jul; 23(1):23-32. PubMed ID: 9250777 [TBL] [Abstract][Full Text] [Related]
35. Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens. Jang YJ; Choi YJ; Lee SH; Jun HK; Choi BK Arch Oral Biol; 2013 Jan; 58(1):17-27. PubMed ID: 22633049 [TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein. Ma L; Li F; Zhang X; Feng X Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062 [TBL] [Abstract][Full Text] [Related]
37. A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis. Abiko Y; Ogura N; Matsuda U; Yanagi K; Takiguchi H Infect Immun; 1997 Sep; 65(9):3966-9. PubMed ID: 9284182 [TBL] [Abstract][Full Text] [Related]
38. Different responses in B cells induced by Porphyromonas gingivalis and Fusobacterium nucleatum. Gemmell E; Seymour GJ Arch Oral Biol; 1992; 37(7):565-73. PubMed ID: 1359860 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of an Actinomyces naeslundii aggregation factor that mediates coaggregation with Porphyromonas gingivalis. Yamaguchi T; Kasamo K; Chuman M; Machigashira M; Inoue M; Sueda T J Periodontal Res; 1998 Nov; 33(8):460-8. PubMed ID: 9879519 [TBL] [Abstract][Full Text] [Related]
40. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats. Hamada N; Watanabe K; Tahara T; Nakazawa K; Ishida I; Shibata Y; Kobayashi T; Yoshie H; Abiko Y; Umemoto T J Periodontol; 2007 May; 78(5):933-9. PubMed ID: 17470029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]